In a study of biomarkers in Alzheimer’s dementia, plasma p-tau217 had greater agreement with CSF and amyloid-PET biomarker ...

Includes Detailed Profiles of Key Players - Siemens Healthineers, GE Healthcare, Eli Lilly & Company, Telix Pharmaceuticals, Bracco Imaging, SOFIE Biosciences, Lantheus Holdings, Curium, Advanced ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

Since Alzheimer’s advanced stage has no cure right now, the entire focus of Zentara is on prevention. For this purpose, it has identified two goals: make early Alzheimer’s diagnosis cheaper and give ...

While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...

Cognitive assessments, brain scans and blood tests are often used to diagnose Alzheimer’s because no single test is definitive. One exam, a tau PET scan, relies on a radioactive tracer injected ...

A new study has found that women with high levels of β-amyloid (Aβ), a protein linked to Alzheimer’s disease, experience ...

A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer’s disease is underway ...

Hormone replacement therapy during menopause appears to be linked to a toxic brain protein that’s a hallmark of Alzhe ...

"Studies have shown that vulnerability to Alzheimer's-related changes in the brain increase in women from pre- to ...

Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...